← Back to Search

Total body water measurement for Obstructive Sleep Apnea

N/A
Waitlist Available
Led By Mrinalini Balki, MD
Research Sponsored by Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up following consent, this measurement will be done, and will take approximately 30 minutes
Awards & highlights

Summary

Obstructive Sleep apnea (OSA) is a common and underdiagnosed condition in obese pregnant women with serious and life-threatening complications to the mother and baby. The investiators propose that a non-invasive method may be used to detect patients at risk of OSA, giving these women access to the necessary treatment to treat this condition. The method is a estimation of body water, which has been shown to be linked to OSA in the non-pregnant population. Body water is estimated by applying surface electrodes to a participant who is lying down by measuring bioimpedance through body tissues by applying a tiny current between the electrodes. The electrical stimulation is not felt by the participant and has no negative effects on mother or baby.

Eligible Conditions
  • Obstructive Sleep Apnea
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~following consent, this measurement will be done, and will take approximately 30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and following consent, this measurement will be done, and will take approximately 30 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Presence of sleep apnea
Secondary study objectives
Height (cm)
Mallampati score
Neck extension
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Total body water measurementExperimental Treatment1 Intervention
Total body water will be measured using Bioelectrical Impedance Analysis (BIA).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bioelectrical Impedance Analysis (BIA)
2014
N/A
~670

Find a Location

Who is running the clinical trial?

Samuel Lunenfeld Research Institute, Mount Sinai HospitalLead Sponsor
127 Previous Clinical Trials
11,191 Total Patients Enrolled
Mrinalini Balki, MDPrincipal InvestigatorMOUNT SINAI HOSPITAL
29 Previous Clinical Trials
1,933 Total Patients Enrolled
~2 spots leftby Dec 2024